Related references
Note: Only part of the references are listed.A phase 1b/2a study of soticlestat as adjunctive therapy in participants with developmental and/or epileptic encephalopathies
Jonathan J. Halford et al.
EPILEPSY RESEARCH (2021)
In Vitro Activation of Cytochrome P450 46A1 (CYP46A1) by Efavirenz-Related Compounds
Natalia Mast et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Therapeutic advances in Dravet syndrome: a targeted literature review
Adam Strzelczyk et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2020)
Soticlestat, a novel cholesterol 24-hydroxylase inhibitor shows a therapeutic potential for neural hyperexcitation in mice
Toshiya Nishi et al.
SCIENTIFIC REPORTS (2020)
CYP46A1 Activation by Efavirenz Leads to Behavioral Improvement without Significant Changes in Amyloid Plaque Load in the Brain of 5XFAD Mice
Alexey M. Petrov et al.
NEUROTHERAPEUTICS (2019)
Progress report on new antiepileptic drugs: A summary of the Fourteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XIV). I. Drugs in preclinical and early clinical development
Meir Bialer et al.
EPILEPSIA (2018)
Cholesterol-metabolizing enzyme cytochrome P450 46A1 as a pharmacologic target for Alzheimer's disease
Natalia Mast et al.
NEUROPHARMACOLOGY (2017)
CYP46A1, the rate-limiting enzyme for cholesterol degradation, is neuroprotective in Huntington's disease
Lydie Boussicault et al.
BRAIN (2016)
CYP46A1 inhibition, brain cholesterol accumulation and neurodegeneration pave the way for Alzheimer's disease
Fathia Djelti et al.
BRAIN (2015)
Binding of a Cyano- and Fluoro-containing Drug Bicalutamide to Cytochrome P450 46A1 UNUSUAL FEATURES AND SPECTRAL RESPONSE
Natalia Mast et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
CYP46A1 T/C polymorphism associated with the APOEε4 allele increases the risk of Alzheimer's disease
Ling Li et al.
JOURNAL OF NEUROLOGY (2013)
The Major Brain Cholesterol Metabolite 24(S)-Hydroxycholesterol Is a Potent Allosteric Modulator of N-Methyl-D-Aspartate Receptors
Steven M. Paul et al.
JOURNAL OF NEUROSCIENCE (2013)
Oxysterols and Parkinson's disease: Evidence that levels of 24S-hydroxycholesterol in cerebrospinal fluid correlates with the duration of the disease
Ingemar Bjorkhem et al.
NEUROSCIENCE LETTERS (2013)
Antifungal Azoles: Structural Insights into Undesired Tight Binding to Cholesterol-Metabolizing CYP46A1
Natalia Mast et al.
MOLECULAR PHARMACOLOGY (2013)
H295R cells as a model for steroidogenic disruption: A broader perspective using simultaneous chemical analysis of 7 key steroid hormones
Frederik Knud Nielsen et al.
TOXICOLOGY IN VITRO (2012)
In Silico and Intuitive Predictions of CYP46A1 Inhibition by Marketed Drugs with Subsequent Enzyme Crystallization in Complex with Fluvoxamine
Natalia Mast et al.
MOLECULAR PHARMACOLOGY (2012)
REFMAC5 for the refinement of macromolecular crystal structures
Garib N. Murshudov et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2011)
MolProbity: all-atom structure validation for macromolecular crystallography
Vincent B. Chen et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2010)
Features and development of Coot
P. Emsley et al.
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2010)
A second class of nuclear receptors for oxysterols: Regulation of RORα and RORγ activity by 24S-hydroxycholesterol (cerebrosterol)
Yongjun Wang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2010)
Structural Basis of Drug Binding to CYP46A1, an Enzyme That Controls Cholesterol Turnover in the Brain
Natalia Mast et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
The antifungal drug voriconazole is an efficient inhibitor of brain cholesterol 24S-hydroxylase in vitro and in vivo
Marjan Shafaati et al.
JOURNAL OF LIPID RESEARCH (2010)
Increased expression of cholesterol 24S-hydroxylase results in disruption of glial glutamate transporter EAAT2 association with lipid rafts: a potential role in Alzheimer's disease
Guilian Tian et al.
JOURNAL OF NEUROCHEMISTRY (2010)
Adeno-associated Virus Gene Therapy With Cholesterol 24-Hydroxylase Reduces the Amyloid Pathology Before or After the Onset of Amyloid Plaques in Mouse Models of Alzheimer's Disease
Eloise Hudry et al.
MOLECULAR THERAPY (2010)
Cholesterol 24-Hydroxylase: An Enzyme of Cholesterol Turnover in the Brain
David W. Russell et al.
ANNUAL REVIEW OF BIOCHEMISTRY (2009)
Use of complementary cation and anion heavy-atom salt derivatives to solve the structure of cytochrome P450 46A1
Mark Andrew White et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2008)
Crystal structures of substrate-bound and substrate-free cytochrome P450 46A1, the principal cholesterol hydroxylase in the brain
Natalia Mast et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
27-hydroxycholesterol is an endogenous SERM that inhibits the cardiovascular effects of estrogen
Michihisa Umetani et al.
NATURE MEDICINE (2007)
Steroidogenic gene expression in H295R cells and the human adrenal gland:: adrenotoxic effects of lindane in vitro
Agneta Oskarsson et al.
JOURNAL OF APPLIED TOXICOLOGY (2006)
Are the CSF levels of 24S-hydroxychole sterol a sensitive biomarker for mild cognitive impairment?
V Leoni et al.
NEUROSCIENCE LETTERS (2006)
Palladium-catalyzed cross-coupling reactions of diazine N-oxides with aryl chlorides, bromides, and iodides
Jean-Philippe Leclerc et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2006)
Cerebrospinal fluid 24S-hydroxycholesterol is increased in patients with Alzheimer's disease compared to healthy controls
P Schönknecht et al.
NEUROSCIENCE LETTERS (2002)
Polymorphism in the cholesterol 24S-hydroxylase gene is associated with Alzheimer's disease
H Kolsch et al.
MOLECULAR PSYCHIATRY (2002)
Share Paper
